MINI FUTURE OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Real-time Bid/Ask 06:34:32 2024-05-31 EDT | ||
| 4.59 EUR / 4.67 EUR | +0.65% |
|
| Current month | -7.26% | ||
| 1 month | -7.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 4.6 | 0.00% |
| 24-05-30 | 4.6 | -1.92% |
| 24-05-29 | 4.69 | +0.43% |
| 24-05-28 | 4.67 | +2.41% |
| 24-05-27 | 4.56 | -0.87% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 02:57 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK1UN8 |
| ISIN | DE000JK1UN86 |
| Date issued | 2024-02-06 |
| Strike | 137.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.8 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.96 € |
|---|---|
| Lowest since issue | 3.91 € |
| Spread | 0.08 € |
| Spread % | 1.72% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
87.89
USD
Average target price
96.55
USD
Spread / Average Target
+9.85%
- Stock Market
- Certificates
- Certificat
